Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab

Lancet. 2023 Mar 4;401(10378):772. doi: 10.1016/S0140-6736(23)00141-1.

Authors

Denis O'Mahony¹, Stephen P Power², Derek G Power³

Affiliations

¹ Department of Geriatric Medicine, Cork University Hospital, Wilton, Cork, Ireland; Department of Medicine, University College Cork, Cork, Ireland. Electronic address: denis.omahony@ucc.ie.
² Department of Radiology, Cork University Hospital, Wilton, Cork, Ireland.
³ Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland.

PMID: 36870727
DOI: 10.1016/S0140-6736(23)00141-1

No abstract available

MeSH terms

Humans
Stomach Neoplasms*
Trastuzumab

Substances

Trastuzumab
ERBB2 protein, human